Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 121

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity

Yokoyama, Masataka, Okada, Sho, Nakagomi, Atsushi, Moriya, Junji, Shimizu, Ippei, Nojima, Aika, Yoshida, Yohko, Ichimiya, Harumi, Kamimura, Naomi, Kobayashi, Yoshio, Ohta, Shigeo, Fruttiger, Marcus, Lozano, Guillermina, Minamino, Tohru · 2014 · Cell Reports

Abstract

Accumulating evidence has suggested a role for p53 activation in various age-associated conditions. Here, we identified a crucial role of endothelial p53 activation in the regulation of glucose homeostasis. Endothelial expression of p53 was markedly upregulated when mice were fed a high-calorie diet. Disruption of endothelial p53 activation improved dietary inactivation of endothelial nitric oxide synthase that upregulated the expression of peroxisome proliferator-activated receptor-γ coactivator-1α in skeletal muscle, thereby increasing mitochondrial biogenesis and oxygen consumption. Mice with endothelial cell-specific p53 deficiency fed a high-calorie diet showed improvement of insulin sensitivity and less fat accumulation, compared with control littermates. Conversely, upregulation of endothelial p53 caused metabolic abnormalities. These results indicate that inhibition of endothelial p53 could be a novel therapeutic target to block the vicious cycle of cardiovascular and metabolic abnormalities associated with obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2014.04.046

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 48

  1. Aguilar, 2007, S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase, Cell Metab., 5, 476, 10.1016/j.cmet.2007.05.006 · DOI · Paper page
  2. Alpert, 2005, Delayed autoregulation of glucose transport in vascular endothelial cells, Diabetologia, 48, 752, 10.1007/s00125-005-1681-y · DOI
  3. Arany, 2008, PGC-1 coactivators and skeletal muscle adaptations in health and disease, Curr. Opin. Genet. Dev., 18, 426, 10.1016/j.gde.2008.07.018 · DOI · Paper page
  4. Barber, 2004, Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes, Stroke, 35, 1720, 10.1161/01.STR.0000129653.22241.d7 · DOI
  5. Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 · DOI · Paper page
  6. Benedito, 2009, The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis, Cell, 137, 1124, 10.1016/j.cell.2009.03.025 · DOI · Paper page
  7. Brodsky, 2004, Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen, Circ. Res., 94, 377, 10.1161/01.RES.0000111802.09964.EF · DOI · Paper page
  8. Butler, 2010, A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes, Diabetes, 59, 323, 10.2337/db09-1471 · DOI · Paper page
  9. Calvo, 2008, Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake, J. Appl. Physiol., 104, 1304, 10.1152/japplphysiol.01231.2007 · DOI · Paper page
  10. Cantley, 1999, New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway, Proc. Natl. Acad. Sci. USA, 96, 4240, 10.1073/pnas.96.8.4240 · DOI · Paper page
  11. Cao, 2013, Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity, Cell Metab., 18, 478, 10.1016/j.cmet.2013.08.008 · DOI · Paper page
  12. Chen, 2006, Premature senescence of endothelial cells: Methusaleh’s dilemma, Am. J. Physiol. Heart Circ. Physiol., 290, H1729, 10.1152/ajpheart.01103.2005 · DOI
  13. Clark, 2008, Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle, Am. J. Physiol. Endocrinol. Metab., 295, E732, 10.1152/ajpendo.90477.2008 · DOI · Paper page
  14. Clark, 2003, Blood flow and muscle metabolism: a focus on insulin action, Am. J. Physiol. Endocrinol. Metab., 284, E241, 10.1152/ajpendo.00408.2002 · DOI · Paper page
  15. Claxton, 2008, Efficient, inducible Cre-recombinase activation in vascular endothelium, Genesis, 46, 74, 10.1002/dvg.20367 · DOI · Paper page
  16. Cousin, 2001, Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1, Endocrinology, 142, 229, 10.1210/endo.142.1.7863 · DOI · Paper page
  17. Czernichow, 2010, Microvascular dysfunction in healthy insulin-sensitive overweight individuals, J. Hypertens., 28, 325, 10.1097/HJH.0b013e328333d1fc · DOI · Paper page
  18. Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
  19. Huang, 2012, Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function, Proc. Natl. Acad. Sci. USA, 109, 17478, 10.1073/pnas.1209281109 · DOI
  20. Jonk, 2007, Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension, Physiology (Bethesda), 22, 252
  21. Kawase, 2009, PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt, Cell, 136, 535, 10.1016/j.cell.2008.12.002 · DOI · Paper page
  22. Kim, 2005, Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism, Mol. Cell. Biol., 25, 9713, 10.1128/MCB.25.21.9713-9723.2005 · DOI
  23. Kim, 2008, p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc, Circ. Res., 103, 1441, 10.1161/CIRCRESAHA.108.181644 · DOI
  24. Kukreja, 2007, eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?, J. Mol. Cell. Cardiol., 42, 280, 10.1016/j.yjmcc.2006.10.011 · DOI
  25. Kumar, 2011, p53 impairs endothelial function by transcriptionally repressing Kruppel-Like Factor 2, Arterioscler. Thromb. Vasc. Biol., 31, 133, 10.1161/ATVBAHA.110.215061 · DOI
  26. Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
  27. Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat. Med., 8, 731, 10.1038/nm724 · DOI · Paper page
  28. Marino, 2000, Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum, Genes Dev., 14, 994, 10.1101/gad.14.8.994 · DOI · Paper page
  29. McTernan, 2003, Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes, J. Clin. Endocrinol. Metab., 88, 6098, 10.1210/jc.2003-030898 · DOI · Paper page
  30. Minamino, 2008, Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes, Nat. Clin. Pract. Cardiovasc. Med., 5, 637, 10.1038/ncpcardio1324 · DOI
  31. Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
  32. Miyauchi, 2004, Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway, EMBO J., 23, 212, 10.1038/sj.emboj.7600045 · DOI · Paper page
  33. Montooth, 2003, Mapping determinants of variation in energy metabolism, respiration and flight in Drosophila, Genetics, 165, 623, 10.1093/genetics/165.2.623 · DOI
  34. Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 · DOI · Paper page
  35. Mortensen, 1999, Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53, J. Biol. Chem., 274, 37679, 10.1074/jbc.274.53.37679 · DOI
  36. Muris, 2012, Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis, Arterioscler. Thromb. Vasc. Biol., 32, 3082, 10.1161/ATVBAHA.112.300291 · DOI
  37. Oike, 2005, Angiopoietin-related growth factor antagonizes obesity and insulin resistance, Nat. Med., 11, 400, 10.1038/nm1214 · DOI · Paper page
  38. Orimo, 2009, Protective role of SIRT1 in diabetic vascular dysfunction, Arterioscler. Thromb. Vasc. Biol., 29, 889, 10.1161/ATVBAHA.109.185694 · DOI · Paper page
  39. Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466, 10.1073/pnas.1032913100 · DOI · Paper page
  40. Plutzky, 2011, Macrovascular effects and safety issues of therapies for type 2 diabetes, Am. J. Cardiol., 108, 25B, 10.1016/j.amjcard.2011.03.014 · DOI
  41. Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 · DOI · Paper page
  42. Rajah, 2001, Differential glucose uptake in retina- and brain-derived endothelial cells, Microvasc. Res., 62, 236, 10.1006/mvre.2001.2337 · DOI
  43. Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
  44. Serrano, 2001, Putting the stress on senescence, Curr. Opin. Cell Biol., 13, 748, 10.1016/S0955-0674(00)00278-7 · DOI · Paper page
  45. Stambolic, 2001, Regulation of PTEN transcription by p53, Mol. Cell, 8, 317, 10.1016/S1097-2765(01)00323-9 · DOI · Paper page
  46. Stewart, 2006, Telomeres: cancer to human aging, Annu. Rev. Cell Dev. Biol., 22, 531, 10.1146/annurev.cellbio.22.010305.104518 · DOI · Paper page
  47. Tang, 2010, The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells, Genesis, 48, 563, 10.1002/dvg.20654 · DOI · Paper page
  48. Vicent, 2003, The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance, J. Clin. Invest., 111, 1373, 10.1172/JCI15211 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., Ohta, S., Fruttiger, M., Lozano, G., & Minamino, T.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2014-06
Volume
7
Issue
5
Pages
1691-1703
ISSN
2211-1247
Cited by
121
References
15
Language
en
Licence
Funders
  • Takeda Science Foundation
  • SENSHIN Medical Research Foundation
  • Uehara Memorial Foundation
  • NOVARTIS Foundation (Japan) for the Promotion of Science
  • Ministry of Education
  • Japan Diabetes Foundation
  • Daiichi Sankyo Foundation of Life Science
  • Life Science Foundation of Japan
  • Naito Foundation
  • Ono Medical Research Foundation
  • Takeda Medical Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity. https://app.cochat.ai/papers/10.1016/j.celrep.2014.04.046
The paper
Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., Ohta, S., Fruttiger, M., Lozano, G., & Minamino, T. (2014). Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity. Cell Reports. https://doi.org/10.1016/j.celrep.2014.04.046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.